(August 21, 2018, 2:37 PM EDT) -- KANSAS CITY, Kan. — A Kansas federal judge overseeing the EpiPen multidistrict litigation on Aug. 20 denied in part and granted in part a motion to dismiss consumer and antitrust class action claims against the manufacturing defendants (In Re: EpiPen [Epinephrine Injection, USP] Marketing, Sales Practices and Antitrust Litigation, MDL Docket No. 2785, No. 17-md-2785, D. Kan., 2018 U.S. Dist. LEXIS 140323)....